Jill Barnes
UW Madison
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jill Barnes as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:02 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06629090 · Brain Blood Vessel Responses to Changes in Blood Flow: Younger CohortUniversity of Wisconsin, Madison · recruiting · Magnetic Resonance Imaging, Cerebrovascular Circulation · principal investigator
- Ph2NCT06629077 · Brain Blood Vessel Responses to Changes in Blood FlowUniversity of Wisconsin, Madison · recruiting · Magnetic Resonance Imaging, Cerebrovascular Circulation · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Cerebrovascular reactivity as a VCID biomarker in CADASILR01AG085602 · NIA · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2024 to 2026 · $736,257 awarded in 2026Same name and institution; not confirmed by an ID
- Impact of cerebral anatomical variations on cerebral perfusion, cerebrovascular reactivity, and biomarkers of cognitive declineR01NS117746 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2024 · $508,302 awarded in 2024Same name and institution; not confirmed by an ID
- Prevalence and impact of cerebral anatomical variations: a risk factor for cognitive decline?R03AG070469 · NIA · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2021 to 2022 · $155,000 awarded in 2022Same name and institution; not confirmed by an ID
- Impact of cerebral anatomical variations on cerebral perfusion, cerebrovascular reactivity, and biomarkers of cognitive declineRF1NS117746 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2020 · $1,929,374 awarded in 2020Grant number is on one of their registry trials
- Cerebral blood flow, connectivity and cognition: the effect of age and exerciseR00HL118154 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2015 to 2017 · $241,307 awarded in 2017Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:02 UTC. The ranking covers the 200 most relevant of 110 PubMed records, and a shared surname and initials can bring in a namesake. All 110 on PubMed
- Sotatercept for the Treatment of Pulmonary Arterial Hypertension.N Engl J Med · 2021520 citationsRCR 35.0
- 251 citationsRCR 16.3
- Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.N Engl J Med · 2018230 citationsRCR 9.7
- 181 citationsRCR 17.3
- Cytisine versus nicotine for smoking cessation.N Engl J Med · 2014154 citationsRCR 5.6
- In vitro and in vivo antioxidant and anti-inflammatory capacities of an antioxidant-rich fruit and berry juice blend. Results of a pilot and randomized, double-blinded, placebo-controlled, crossover study.J Agric Food Chem · 2008117 citationsRCR 4.3
- Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.J Neurol · 2008113 citationsRCR 3.2
- 103 citationsRCR 5.4
- Ellagitannin consumption improves strength recovery 2-3 d after eccentric exercise.Med Sci Sports Exerc · 2010101 citationsRCR 4.2
- Aging enhances autonomic support of blood pressure in women.Hypertension · 201499 citationsRCR 3.7